Transcriptomic and proteomic profiling of glial versus neuronal Dube3a overexpression reveals common molecular changes in gliopathic epilepsies

Epilepsy affects millions of individuals worldwide and many cases are pharmacoresistant. Duplication 15q syndrome (Dup15q) is a genetic disorder caused by duplications of the 15q11.2-q13.1 region. Phenotypes include a high rate of pharmacoresistant epilepsy. We developed a Dup15q model in Drosophila...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 141; p. 104879
Main Authors Hope, Kevin A., Johnson, Daniel, Miller, P. Winston, Lopez-Ferrer, Daniel, Kakhniashvili, David, Reiter, Lawrence T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epilepsy affects millions of individuals worldwide and many cases are pharmacoresistant. Duplication 15q syndrome (Dup15q) is a genetic disorder caused by duplications of the 15q11.2-q13.1 region. Phenotypes include a high rate of pharmacoresistant epilepsy. We developed a Dup15q model in Drosophila melanogaster that recapitulates seizures in Dup15q by over-expressing fly Dube3a or human UBE3A in glial cells, but not neurons, implicating glia in the Dup15q epilepsy phenotype. We compared Dube3a overexpression in glia (repo>Dube3a) versus neurons (elav>Dube3a) using transcriptomics and proteomics of whole fly head extracts. We identified 851 transcripts differentially regulated in repo>Dube3a, including an upregulation of glutathione S-transferase (GST) genes that occurred cell autonomously within glial cells. We reliably measured approximately 2,500 proteins by proteomics, most of which were also quantified at the transcript level. Combined transcriptomic and proteomic analysis revealed an enrichment of 21 synaptic transmission genes downregulated at the transcript and protein in repo>Dube3a indicating synaptic proteins change in a cell non-autonomous manner in repo>Dube3a flies. We identified 6 additional glia originating bang-sensitive seizure lines and found upregulation of GSTs in 4 out of these 6 lines. These data suggest GST upregulation is common among gliopathic seizures and may ultimately provide insight for treating epilepsy. •Combining RNAseq and proteomics is a powerful approach to investigate disease mechanisms.•Glial expression of Dube3a causes a cell non-autonomous reduction of synaptic proteins and autonomous upregulation of GST genes.•GST upregulation is common across gliopathic seizure lines, suggesting a common molecular mechanism among gliopathic seizures.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
KH designed experiments, executed experiments, performed data analysis and wrote the manuscript; DJ and PWM assisted in bioinformatic analysis; DLF provided proteomics support; DK ran proteomics samples and LTR provided funding, directed these studies and assisted in writing the manuscript.
Author Credit Statement
Current Address: Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT
ISSN:0969-9961
1095-953X
DOI:10.1016/j.nbd.2020.104879